CD155 as a prognostic and predictive biomarker in acute myeloid leukemia

Abstract Background Acute myeloid leukemia (AML) is a heterogeneous hematological malignancy with different molecular and genetic alterations. CD155 is expressed on myeloid cells and serves as a recognition molecule for natural killer (NK) cells to induce cytotoxicity. This study aimed to assess the...

Full description

Bibliographic Details

Published in:	Discover Oncology
Main Authors:	Ashraf Zeidan Abdalla, Salah Mabrouk Khallaf, Asmaa Mohammed Zahran, Nehal Adel Rayan, Ahmed Refaat Abd Elzaher
Format:	Article
Language:	English
Published:	Springer 2025-05-01
Subjects:	Acute Myeloid Leukemia CD155 Survival
Online Access:	https://doi.org/10.1007/s12672-025-02665-2